文献速递临床微生物分子诊断

应用MALDI Biotyper Sirius质谱系统检测大肠埃希菌黏菌素耐药性

Detection of Colistin Resistance in Escherichia coli by Use of the MALDI Biotyper Sirius Mass Spectrometry System.
PubMed 文献 · J Clin Microbiol · 2019-11-22

本研究将MALDIxin试验适配于临床常用的MALDI Biotyper Sirius质谱系统,使用6株表达MCR蛋白的大肠埃希菌克隆优化样本制备,并用40株临床分离株(19株确认产MCR蛋白、12株黏菌素耐药但常见mcr基因阴性、9株多黏菌素敏感)验证。结果显示,所有敏感株的多黏菌素耐药比值(PRR)为0,所有耐药株PRR为正值,与耐药遗传基础无关。

要点

  • 适配MALDI Biotyper Sirius系统的MALDIxin试验可在15分钟内检测大肠埃希菌黏菌素耐药性。
  • 所有黏菌素敏感大肠埃希菌PRR为0,所有耐药株PRR为正值,与耐药机制无关。
  • 该优化方法快速、经济、高通量,但仅为初步可行性研究。

核心结论

  • 适配MALDI Biotyper Sirius系统的优化MALDIxin试验可无偏、快速、可靠、经济、高通量地检测临床大肠埃希菌分离株的黏菌素耐药性。

研究设计与样本

  • 采用6株表达MCR蛋白的大肠埃希菌克隆优化样本制备方案,并用40株大肠埃希菌临床分离株(19株确认产MCR蛋白、12株黏菌素耐药但常见mcr基因阴性、9株多黏菌素敏感)验证试验。

主要发现

  • 所有黏菌素敏感大肠埃希菌分离株的PRR值为0,所有耐药株的PRR值为正值,与耐药遗传基础无关。

关键数值与推荐

  • PRR值为0提示多黏菌素敏感,PRR为正值提示多黏菌素耐药。

临床怎么用

  • 该优化MALDIxin试验适配常规MALDI Biotyper Sirius系统,可用于临床大肠埃希菌黏菌素耐药性的快速检测。

局限性

  • 本研究为初步可行性研究,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Polymyxin antibiotics are a last-line treatment for multidrug-resistant Gram-negative bacteria. However, the emergence of colistin resistance, including the spread of mobile mcr genes, necessitates the development of improved diagnostics for the detection of colistin-resistant organisms in hospital settings. The recently developed MALDIxin test enables detection of colistin resistance by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in less than 15 min but is not optimized for the mass spectrometers commonly found in clinical microbiology laboratories. In this study, we adapted the MALDIxin test for the MALDI Biotyper Sirius MALDI-TOF MS system (Bruker Daltonics). We optimized the sample preparation protocol by using a set of 6 mobile colistin resistance (MCR) protein-expressing Escherichia coli clones and validated the assay with a collection of 40 E. coli clinical isolates, including 19 confirmed MCR protein producers, 12 colistin-resistant isolates that tested negative for commonly encountered mcr genes (i.e., likely chromosomally resistant isolates), and 9 polymyxin-susceptible isolates. We calculated polymyxin resistance ratio (PRR) values from the acquired spectra; PRR values of 0, indicating polymyxin susceptibility, were obtained for all colistin-susceptible E. coli isolates, whereas positive PRR values, indicating resistance to polymyxins, were obtained for all resistant strains, independent of the genetic basis of resistance. Thus, we report a preliminary feasibility study showing that an optimized version of the MALDIxin test adapted for the routine MALDI Biotyper Sirius system provides an unbiased, fast, reliable, cost-effective, and high-throughput way of detecting colistin resistance in clinical E. coli isolates.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Furniss RCD, Dortet L, Bolland W, et al. Detection of Colistin Resistance in Escherichia coli by Use of the MALDI Biotyper Sirius Mass Spectrometry System. J Clin Microbiol. 2019. PMID: 31597744. doi:10.1128/JCM.01427-19

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。